Atropos Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
733 Industrial Rd, San Carlos, Californi...Website
www.atroposthera.comRevenue
$8.3 MillionIndustry
About Atropos Therapeutics
Atropos Therapeutics Org Chart
Is Atropos Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Atropos Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Atropos Therapeutics recently announced quarterly report
Product Launch: Get notified when Atropos Therapeutics launches new products
Atropos Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Atropos Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Atropos Therapeutics
Check out if Atropos Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Atropos Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Atropos Therapeutics
Find more new buyers
Compare Similar Companies to Atropos Therapeutics
Compare insights from companies similar to Atropos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Atropos Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Atropos Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Atropos Therapeutics.
Atropos Therapeutics financials insights
Gather financial insights about Atropos Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$34K
Atropos Therapeutics Tech Stack
A closer look at the technologies used by Atropos Therapeutics
Atropos Therapeutics News & Media
Atomwise and Atropos Launch Joint Venture to Discover Senescence Modulating Small Molecules for Cancer Patients
SAN FRANCISCO & BELMONT, Calif.--(BUSINESS WIRE)--Atomwise Inc., a leader in artificial intelligence (AI) for drug discovery, and Atropos Therapeutics, Inc., a senescence platform discovery company, announced today that they will launch a joint venture company to discover and advance a pipeline of compounds for promising discovery targets for the treatment of cancer. Cellular senescence is a regulated biological process by which cells stop dividing irreversibly and is a normal part of aging.
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Atropos Therapeutics
Atropos Therapeutics focuses on developing novel senescence-targeting drugs aimed at treating aging-related diseases and cancer. The company is dedicated to improving healthspan through innovative therapies. Their target clients include individuals affected by age-related conditions and cancer. Atropos is committed to advancing the science of senot... Read More